New Granted Patent Listed in FDA’s Orange Book for AMZEEQ
VYNE Therapeutics Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (minocycline) topical foam, 4%
New Granted Patent Listed in FDA’s Orange Book for AMZEEQ
